What is NovoCure's quick ratio?

NovoCure (NVCR) reported quick ratio of 2.7× in Q1 2026.

How has NovoCure's quick ratio changed year-over-year?

NovoCure's quick ratio increased by 91.4% year-over-year, from 1.4× to 2.7×.

What is the long-term trend for NovoCure's quick ratio?

Over 5 years (2020 to 2025), NovoCure's quick ratio has grown at a -20.5% compound annual growth rate (CAGR), from 8.6× to 2.7×.

What does quick ratio mean?

Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.

NovoCure NVCR Quick ratio

Quick ratio at other companies

Boston ScientificBSX

1.2×+0.3×

MedtronicMDT

1.6×+0.2×

Iovance Biotherapeutics, Inc.IOVA

3.2×-0.5×

Nuvation BioNUVB

7.2×-1.8×

Vir Biotechnology, Inc.VIR

7.1×+0.3×

Syndax PharmaceuticalsSNDX

5.1×-0.7×

Other financials

Income statement

See full

Revenue$174.1M+12.3%

Gross profit$135.1M+16.0%

Operating income-$67.4M-78.1%

Net income-$71.1M-107%

EPS (diluted)-$0.62-100%

Balance sheet

See full

Cash & equivalents$87.5M-31.2%

Total debt$39.5M-2.1%

Total equity$330.7M-8.6%

Total assets$787.9M-36.9%

Cash flow

See full

Operating cash flow-$13.5M+62.1%

CapEx$5.2M-51.4%

Free cash flow-$18.7M+59.7%

Valuation

See full

Market cap$1.7B-36.7%

Profitability

See full

Gross margin75.2%-2.0pp

Operating margin-27.2%+0.4pp

Net margin-25.7%-0.7pp

FCF margin-7.1%-2.0pp

Returns & leverage

See full

Return on equity-50%+5.4pp

Debt / equity0.1×0.0×

Current ratio2.9×+1.4×

Where this comes from

Calculated from NovoCure’s reported figures.

quick assets/total current liabilities=2.7×

Based on the most recent quarter.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NovoCure's quick ratio?: NovoCure (NVCR) reported quick ratio of 2.7× in Q1 2026.
How has NovoCure's quick ratio changed year-over-year?: NovoCure's quick ratio increased by 91.4% year-over-year, from 1.4× to 2.7×.
What is the long-term trend for NovoCure's quick ratio?: Over 5 years (2020 to 2025), NovoCure's quick ratio has grown at a -20.5% compound annual growth rate (CAGR), from 8.6× to 2.7×.
What does quick ratio mean?: Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.